Don't Buy UnitedHealth Group (UNH) Stock Before Reading This

While UnitedHealth Group operates in the growing healthcare industry and has strong long-term performance, the article advises caution due to slow recent growth (2% revenue growth), ongoing DOJ investigations into Medicare billing practices, claims denial lawsuits, and challenges in its Medicare Advantage program forcing membership reductions. Despite AI investments and attractive valuation metrics, these headwinds make it a less compelling investment opportunity.